These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3065346)

  • 1. Simultaneous analysis of methylprednisolone hemisuccinate, cortisol and methylprednisolone by normal-phase high-performance liquid chromatography in human plasma.
    Kong AN; Slaughter RL; Jusko WJ
    J Chromatogr; 1988 Nov; 432():308-14. PubMed ID: 3065346
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses.
    Möllmann H; Rohdewald P; Barth J; Möllmann C; Verho M; Derendorf H
    Pharm Res; 1988 Aug; 5(8):509-13. PubMed ID: 3072558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid method for the measurement of methylprednisolone and its hemisuccinate in plasma and urine following "pulse therapy" by high-performance liquid chromatography.
    Lawson GJ
    J Chromatogr; 1985 Aug; 342(2):251-60. PubMed ID: 3902861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of methylprednisolone and its hemisuccinate ester.
    Derendorf H; Möllmann H; Rohdewald P; Rehder J; Schmidt EW
    Clin Pharmacol Ther; 1985 May; 37(5):502-7. PubMed ID: 3886255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.
    Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol.
    Kandrotas RJ; Slaughter RL; Brass C; Jusko WJ
    Clin Pharmacol Ther; 1987 Oct; 42(4):465-70. PubMed ID: 3311551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.
    Ludwig EA; Kong AN; Camara DS; Jusko WJ
    J Clin Pharmacol; 1993 Sep; 33(9):805-10. PubMed ID: 8227476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis.
    Ebling WF; Szefler SJ; Jusko WJ
    J Chromatogr; 1984 Feb; 305(2):271-80. PubMed ID: 6368578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.
    Kong AN; Ludwig EA; Slaughter RL; DiStefano PM; DeMasi J; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):616-28. PubMed ID: 2689044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of hydrocortisone and methylprednisolone and their hemisuccinate esters in human serum.
    Smith MD
    J Chromatogr; 1979 Oct; 164(2):129-37. PubMed ID: 541404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic assay for methylprednisolone and its soluble prodrug esters in dog plasma.
    Shah JA; Weber DJ
    J Chromatogr; 1985 Nov; 344():41-9. PubMed ID: 3910669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma.
    Parker TJ; Daley-Yates PT; Wood SA
    Br J Clin Pharmacol; 1997 Jun; 43(6):589-92. PubMed ID: 9205818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury.
    Barth J; Winkler J; Schumann R; Nagaraja NV; Madabushi R; Balbach S; Derendorf H; Möllmann H; Möllenhoff G
    Int J Clin Pharmacol Ther; 2004 Sep; 42(9):504-11. PubMed ID: 15487809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.
    Dunn TE; Ludwig EA; Slaughter RL; Camara DS; Jusko WJ
    Clin Pharmacol Ther; 1991 May; 49(5):536-49. PubMed ID: 1827621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous analysis of methylprednisolone, methylprednisolone succinate, and endogenous corticosterone in rat plasma.
    Mehvar R; Dann RO; Hoganson DA
    J Pharm Biomed Anal; 2000 Jul; 22(6):1015-22. PubMed ID: 10857570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone.
    Daley-Yates PT; Gregory AJ; Brooks CD
    Br J Clin Pharmacol; 1997 Jun; 43(6):593-601. PubMed ID: 9205819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of methylprednisolone and hydrocortisone in plasma using high pressure liquid chromatography.
    Garg DC; Ayres JW; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):137-46. PubMed ID: 905626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolysis of methylprednisolone hemisuccinate to methylprednisolone by a nonspecific carboxylesterase.
    Oshima T; Nakajima E; Hattori K
    Pharmacol Res Commun; 1980 Feb; 12(2):139-46. PubMed ID: 6992149
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of methylprednisolone in cat plasma and spinal cord following a single intravenous dose of the sodium succinate ester.
    Braughler JM; Hall ED
    Drug Metab Dispos; 1982; 10(5):551-2. PubMed ID: 6128209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.